Category: Latest News

Linearis Welcomes John Reichenbach as a New Advisor Quebec City, March 10th, 2025- Linearis is excited to welcome John Reichenbach as a new strategic advisor to its list of world-renowned strategic collaborators. John Reichenbach brings extensive executive leadership experience to his advisory role, having served in multiple C-suite positions across venture capital-backed technology companies. He…

Linearis Unveils Its Investments and Inaugurates Its New Metabolomics Laboratory In the presence of Mr. Bruno Marchand, Mayor of Quebec City and guest speakers includingFabrice Brunet (QIS), Jacques Corbeil (Linearis), Stéphanie Doyle (Montreal Invivo), Annie-Kim Gilbert (MEDTEQ+), Diane Gosselin (CQDM), Benoit Larose (Bio Quebec), Francois-Thomas Michaud (Feldan), Laurent Tillement (Mila), Jesse Vincent-Herscovici (Axelys) Tour the new…

Feldan Therapeutics Accelerates Growth With Strategic Investment From Linearis Ventures Quebec City, Canada – February 18, 2025 – Feldan Therapeutics (“Feldan”), a clinical-stage pharmaceutical company specialized in the development of treatments based on intracellular delivery of therapeutics, is pleased to announce an investment from Linearis Ventures, supported by Ville de Québec. This funding is in…

Linearis is Pioneering Large Scale Metabolomic Analysis: A Pan-Canadian Collaboration and New Frontier in Cancer Precision Medicine November 12th 2024 Quebec City (Canada)— Linearis with its tandem Ventures Fund and Laboratory is pioneering and supporting discoveries to prevent, detect and cure metabolic diseases including cancers & diabetes through artificial intelligence (AI)-life science precision medicine projects.…

Linearis Ventures and Other Funds Invest in Noetik’s Oversubscribed Series A $40M USD Accelerating AI-Drug Development Platform for Precision Cancer Therapies August 29, 2024 16:00 Eastern Daylight Time Quebec City, Canada- Linearis Ventures, a life science VC fund focusing on AI-enabling healthcare, is thrilled to confirm its investment in Noetik’s oversubscribed $40M USD Series A…

Linearis Partners with Mila in a Vast Biomanufacturing Funding Initiative Québec, May 8, 2024 — Linearis and Mila are pleased to announce a strategic partnership to support artificial intelligence (AI) and drug discovery. This collaboration will aim to bridge the gap between AI models and experimental laboratory results ensuring faster drug development to foster safe…

Quebec City, Canada, February 8th 2024 – The City of Quebec today announced a $3M contribution to the Linearis Ventures’ fund establishing its Quebec City headquarters in the former Medicago laboratories (a subsidiary of Mitsubishi). Thus, the fund has exceeded 33% of its first commitment target of $50M. With this leverage effect, the City of…

https://vimeo.com/983745132 Leveraging artificial intelligence (AI), Linearis provides a comprehensive health status based on the analysis of ∼1,300 metabolomic biomarkers through mass spectrometry. The platform will enable its clients to improve prevention, screening, treatment monitoring, and new drug discovery. Québec, Canada, November 28, 2023- Linearis Labs Inc (“Linearis”), an innovative company at the intersection of AI…